189 related articles for article (PubMed ID: 21865121)
1. Differentiation between basal cell carcinoma and trichoepithelioma by immunohistochemical staining of the androgen receptor: an overview.
Arits AH; Van Marion AM; Lohman BG; Thissen MR; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Eur J Dermatol; 2011; 21(6):870-3. PubMed ID: 21865121
[TBL] [Abstract][Full Text] [Related]
2. PHLDA1 (TDAG51) is a follicular stem cell marker and differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma.
Sellheyer K; Krahl D
Br J Dermatol; 2011 Jan; 164(1):141-7. PubMed ID: 20846311
[TBL] [Abstract][Full Text] [Related]
3. Elastic fiber staining and cytokeratin 15 expression pattern in trichoepithelioma and basal cell carcinoma.
Choi CW; Park HS; Kim YK; Lee SH; Cho KH
J Dermatol; 2008 Aug; 35(8):499-502. PubMed ID: 18789069
[TBL] [Abstract][Full Text] [Related]
4. Does the panel of cytokeratin 20 and androgen receptor antibodies differentiate desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma?
Katona TM; Perkins SM; Billings SD
J Cutan Pathol; 2008 Feb; 35(2):174-9. PubMed ID: 18190441
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of Basal Cell Carcinoma and Trichoepithelioma: An Immunohistochemical Study.
Carrasquillo OY; Cruzval-O'Reilly E; Sánchez JE; Valentín-Nogueras SM
Am J Dermatopathol; 2021 Mar; 43(3):191-197. PubMed ID: 32809979
[TBL] [Abstract][Full Text] [Related]
6. CD10 expression in trichoepithelioma and basal cell carcinoma.
Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of immunohistochemical markers in differentiation between basal cell carcinoma and trichoepithelioma in small biopsy specimens.
Mostafa NA; Assaf M; Elhakim S; Abdel-Halim MRE; El-Nabarawy E; Gharib K
J Cutan Pathol; 2018 Nov; 45(11):807-816. PubMed ID: 29917261
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of cytokeratin 15, TDAG51, cytokeratin 20 and androgen receptor in sclerosing adnexal neoplasms and variants of basal cell carcinoma.
Evangelista MT; North JP
J Cutan Pathol; 2015 Nov; 42(11):824-31. PubMed ID: 26016446
[TBL] [Abstract][Full Text] [Related]
9. Desmoplastic trichoepithelioma versus morphoeic basal cell carcinoma: a critical reappraisal of histomorphological and immunohistochemical criteria for differentiation.
Costache M; Bresch M; Böer A
Histopathology; 2008 Jun; 52(7):865-76. PubMed ID: 18462369
[TBL] [Abstract][Full Text] [Related]
10. Desmoplastic Trichoepithelioma: An Uncommon but Diagnostically Problematic Benign Adnexal Tumor.
Bartoš V
Acta Dermatovenerol Croat; 2019 Dec; 27(4):282-284. PubMed ID: 31969246
[TBL] [Abstract][Full Text] [Related]
11. The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers.
Sellheyer K; Nelson P; Kutzner H; Patel RM
J Cutan Pathol; 2013 Apr; 40(4):363-70. PubMed ID: 23398472
[TBL] [Abstract][Full Text] [Related]
12. Advanced differentiation in trichoepithelioma and basal cell carcinoma investigated by immunohistochemistry against neurofilaments.
Fernandez-Flores A
Folia Histochem Cytobiol; 2009; 47(1):61-4. PubMed ID: 19419939
[TBL] [Abstract][Full Text] [Related]
13. CD10 for the distinct differential diagnosis of basal cell carcinoma and benign tumours of cutaneous appendages originating from hair follicle.
Sengul D; Sengul I; Astarci MH; Ustun H; Mocan G
Pol J Pathol; 2010; 61(3):140-6. PubMed ID: 21225496
[TBL] [Abstract][Full Text] [Related]
14. Immunolabeling pattern of podoplanin (d2-40) may distinguish basal cell carcinomas from trichoepitheliomas: a clinicopathologic and immunohistochemical study of 49 cases.
Plaza JA; Ortega PF; Bengana C; Stockman DL; Suster S
Am J Dermatopathol; 2010 Oct; 32(7):683-7. PubMed ID: 20559122
[TBL] [Abstract][Full Text] [Related]
15. Comparative examination of androgen receptor reactivity for differential diagnosis of sebaceous carcinoma from squamous cell and basal cell carcinoma.
Asadi-Amoli F; Khoshnevis F; Haeri H; Jahanzad I; Pazira R; Shahsiah R
Am J Clin Pathol; 2010 Jul; 134(1):22-6. PubMed ID: 20551262
[TBL] [Abstract][Full Text] [Related]
16. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.
Fan YS; Carr RA; Sanders DS; Smith AP; Lazar AJ; Calonje E
Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083
[TBL] [Abstract][Full Text] [Related]
17. Expression of androgen receptor by fibroepithelioma of Pinkus: evidence supporting classification as a basal cell carcinoma variant?
Katona TM; Ravis SM; Perkins SM; Moores WB; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):7-12. PubMed ID: 17284955
[TBL] [Abstract][Full Text] [Related]
18. Increased immunoreactivity of membrane type-1 matrix metalloproteinase (MT1-MMP) and β-catenin in high-risk basal cell carcinoma.
Oh ST; Kim HS; Yoo NJ; Lee WS; Cho BK; Reichrath J
Br J Dermatol; 2011 Dec; 165(6):1197-204. PubMed ID: 21729023
[TBL] [Abstract][Full Text] [Related]
19. The use of antidesmoglein stains in Mohs micrographic surgery. A potential aid for the differentiation of basal cell carcinoma from horizontal sections of the hair follicle and folliculocentric basaloid proliferation.
Krunic AL; Garrod DR; Viehman GE; Madani S; Buchanan MD; Clark RE
Dermatol Surg; 1997 Jun; 23(6):463-8. PubMed ID: 9217798
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of PHLDA1 (TDAG51) in basal cell carcinoma and trichoepithelioma.
Yeh I; McCalmont TH; LeBoit PE
Br J Dermatol; 2012 Nov; 167(5):1106-10. PubMed ID: 22958125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
